Does LENALIDOMIDE Cause Product dose omission issue? 8,145 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8,145 reports of Product dose omission issue have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 2.3% of all adverse event reports for LENALIDOMIDE.
8,145
Reports of Product dose omission issue with LENALIDOMIDE
2.3%
of all LENALIDOMIDE reports
24
Deaths
691
Hospitalizations
How Dangerous Is Product dose omission issue From LENALIDOMIDE?
Of the 8,145 reports, 24 (0.3%) resulted in death, 691 (8.5%) required hospitalization, and 12 (0.1%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 8,145 reports have been filed with the FAERS database.
What Other Side Effects Does LENALIDOMIDE Cause?
Diarrhoea (27,576)
Fatigue (22,956)
Death (19,213)
Off label use (17,017)
Rash (15,794)
Pneumonia (14,807)
Plasma cell myeloma (14,191)
Neuropathy peripheral (10,215)
White blood cell count decreased (9,996)
Constipation (9,635)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
GOLIMUMAB (4,216)
Which LENALIDOMIDE Alternatives Have Lower Product dose omission issue Risk?
LENALIDOMIDE vs LENIOLISIB
LENALIDOMIDE vs LENOGRASTIM
LENALIDOMIDE vs LENVATINIB
LENALIDOMIDE vs LEPONEX
LENALIDOMIDE vs LERCANIDIPINE